Bactiguard Holding AB (publ) (BACTI-B.ST)
SEK 37.2
(-2.11%)
SEK 37.2
(-2.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -52.33 Million | 3.06 Million | 7.25 Million | 702 Thousand | 53.98 Million | -16.69 Million |
| Net Income | -138.38 Million | -52.87 Million | -58.77 Million | -38.38 Million | 16.25 Million | -14.93 Million |
| Depreciation & Amortization | 43.64 Million | 49.24 Million | 47 Million | 44.29 Million | 42.12 Million | 34.19 Million |
| Deferred income taxes | -8.77 Million | -7 Million | -4.81 Million | -6.15 Million | -5.91 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 13.76 Million | 13.46 Million | 22.1 Million | -13.53 Million | 1.3 Million | -16.69 Million |
| Other non-cash items | 115.57 Million | -6.77 Million | -3.08 Million | 8.33 Million | -5.7 Million | -19.26 Million |
| Investing Cash Flow | -8.6 Million | -10.91 Million | -7.29 Million | -57.01 Million | -4.42 Million | -5.74 Million |
| Investments in PPE | -8.6 Million | -10.91 Million | -7.29 Million | -15.35 Million | -4.42 Million | -5.74 Million |
| Acquisitions | - | - | - | -41.66 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.42 Million | -1.07 Million | -1000.00 | -4.9 Million | -2.88 Million | -5.02 Million |
| Financing Cash Flow | -11.83 Million | -13.89 Million | 205.82 Million | 46.2 Million | -27.82 Million | -5.06 Million |
| Debt repayment | -696 Thousand | -900 Thousand | -562 Thousand | -1.37 Million | -15 Million | -7.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 228 Million | - | - | - |
| Other Financing Activities | -11.13 Million | -12.99 Million | -21.61 Million | 47.58 Million | -12.82 Million | 2.43 Million |
| Accounts receivables | 18 Million | 1.94 Million | 416 Thousand | 2.26 Million | 7.33 Million | -4.04 Million |
| Accounts payables | -17.12 Million | 4.11 Million | 17.99 Million | -730 Thousand | 1.53 Million | 2.21 Million |
| Inventory | 8.25 Million | -7.93 Million | -3.72 Million | -5.05 Million | 150 Thousand | -427 Thousand |
| Other working capital | 4.63 Million | 15.34 Million | 7.41 Million | -10.02 Million | -7.71 Million | -16.26 Million |
| Cash at beginning of period | 197.72 Million | 217.58 Million | 9.88 Million | 22.87 Million | 1.89 Million | 11.55 Million |
| Cash at end of period | 123.21 Million | 197.72 Million | 217.58 Million | 9.88 Million | 22.87 Million | 1.89 Million |
| Capital Expenditure | -8.6 Million | -10.91 Million | -7.29 Million | -15.35 Million | -4.42 Million | -5.74 Million |
| Effect of forex changes on cash | -1.73 Million | 1.88 Million | 1.91 Million | -2.88 Million | -748 Thousand | 285 Thousand |
| Net cash flow / Change in cash | -74.51 Million | -19.86 Million | 207.7 Million | -12.99 Million | 20.98 Million | -9.65 Million |
| Free Cash Flow | -60.94 Million | -7.85 Million | -38 Thousand | -14.64 Million | 49.55 Million | -22.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.67 Million | -14.31 Million | -9.9 Million | -138.38 Million | -27.21 Million | -24.6 Million |
| Depreciation & Amortization | 19.02 Million | 12.05 Million | 11.36 Million | 43.64 Million | 19.54 Million | 7.68 Million |
| Deferred income taxes | - | - | - | -8.77 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.01 Million | 22.13 Million | -11.25 Million | 13.76 Million | 8.39 Million | -18.08 Million |
| Other non-cash items | -1000.00 | 5.5 Million | 30.25 Million | 115.57 Million | 9.38 Million | 23.27 Million |
| Investing Cash Flow | -2.89 Million | -3.95 Million | -6.22 Million | -8.6 Million | -6.04 Million | -708 Thousand |
| Investments in PPE | -2.89 Million | -3.95 Million | -6.22 Million | -8.6 Million | -6.04 Million | -902 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -1.42 Million | - | 194 Thousand |
| Financing Cash Flow | -3.89 Million | -3.33 Million | -6.33 Million | -11.83 Million | -3.83 Million | -3.01 Million |
| Debt repayment | -255 Thousand | -295 Thousand | -3.75 Million | -696 Thousand | -7.63 Million | -2.79 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.64 Million | -3.63 Million | - | -11.13 Million | -2.8 Million | -222 Thousand |
| Accounts receivables | -10.84 Million | 3.06 Million | -21.03 Million | 18 Million | 14.75 Million | -3.41 Million |
| Accounts payables | -6.72 Million | 18.76 Million | 3.06 Million | -17.12 Million | -1.65 Million | 2.11 Million |
| Inventory | 12.02 Million | -6.25 Million | 1.17 Million | 8.25 Million | 9.53 Million | -2.21 Million |
| Other working capital | -7.19 Million | 6.54 Million | 5.53 Million | 4.63 Million | -14.23 Million | -14.56 Million |
| Cash at beginning of period | 105.27 Million | 95.83 Million | 123.21 Million | 197.72 Million | 124.41 Million | 163.33 Million |
| Cash at end of period | 106.42 Million | 105.27 Million | 95.83 Million | 123.21 Million | 123.21 Million | 124.41 Million |
| Capital Expenditure | -2.89 Million | -3.95 Million | -6.22 Million | -8.6 Million | -6.04 Million | -902 Thousand |
| Effect of forex changes on cash | -410 Thousand | -112 Thousand | 4.23 Million | -1.73 Million | -1.43 Million | -186 Thousand |
| Net cash flow / Change in cash | 1.14 Million | 9.43 Million | -27.37 Million | -74.51 Million | -1.19 Million | -38.91 Million |
| Free Cash Flow | 5.45 Million | 12.88 Million | -25.28 Million | -60.94 Million | 4.06 Million | -35.91 Million |
GNE
000690
6116
HPURF
3219
8464